Abstract
Endoscopic ultrasound-guided (EUS) radiofrequency (RFA) and ethanol ablation for pancreatic neuroendocrine tumors (PNETs) have been reported to have promising results in recent studies. We conducted a systematic review and meta-analysis studying the effectiveness and safety of EUS-RFA ablation as compared to EUS ethanol ablation.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have